Literature DB >> 6111028

Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs.

G Gross, H J Schümann.   

Abstract

The effect of different neuroleptic drugs (levomepromazine, haloperidol, thioridazine, clozapine and sulpiride) on (-)-3H-noradrenaline uptake and release by parieto-occipital slices of the rat cerebral cortex was investigated. 1. All neuroleptic drugs tested increased the 3H-efflux from electrically stimulated cortical slices preincubated in (-)-3H-noradrenaline already at 1 microM, clozapine was the most potent compound followed by haloperidol, thioridazine, levomepromazine and sulpiride. The enhanced 3H-efflux due to field stimulation was found at concentrations, which did not increase the basal 3H-efflux. Only haloperidol raised the basal 3H-efflux at 1 microM. 2. All neuroleptic drugs failed to inhibit (-)-3H-noradrenaline (10(-7) M) accumulation by cortical slices at 1 microM. Sulpiride was inactive in concentrations up to 100 microM. Clozapine again proved to be most potent at 10-100 microM. 3. Clozapine was able to enhance the stimulated transmitter overflow when noradrenaline uptake was already blocked by cocaine thus indicating a different mode of action. 4. Clozapine and levomepromazine antagonized the presynaptic alpha-adrenergic effect of clonidine. 5. The antidepressant drug amitriptyline increased the transmitter efflux at the same concentrations and to a similar extent as neuroleptic agents. It is concluded that neuroleptics enhance the stimulation induced noradrenaline release mainly by acting on presynaptic alpha-adrenoceptors. The effect of clozapine, however, includes a noradrenaline uptake inhibition. These findings may explain the increased noradrenaline turnover produced by neuroleptic drugs and the weak antidepressant action of low potent neuroleptics as well.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6111028     DOI: 10.1007/bf00499252

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine.

Authors:  P A Baumann; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  Effect of butyrophenones on the sympathetic nerves of the isolated rabbit heart and on the postsynaptic alpha-adrenoceptors of the isolated rabbit aorta.

Authors:  M Göthert; H J Lox; J M Rieckesmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

3.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

4.  Presynaptic receptor systems on the noradrenergic neurones of rat brain.

Authors:  H D Taube; K Starke; E Borowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

5.  Mianserin--an analysis of its peripheral autonomic actions.

Authors:  J C Doxey; J Everitt; G Metcalf
Journal:  Eur J Pharmacol       Date:  1978-09-01       Impact factor: 4.432

6.  Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

Authors:  K Starke; H Montel
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

7.  Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

8.  An examination of the negative feedback function of presynaptic adrenoceptors in a vascular tissue.

Authors:  C C Chan; S Kalsner
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

9.  Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

10.  Clozapine induced increase of human plasma norepinephrine.

Authors:  M Sarafoff; L Davis; E Rüther
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more
  7 in total

Review 1.  The drug management of severe alcohol withdrawal syndrome.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Haloperidol facilitates memory retrieval in the rat.

Authors:  S J Sara
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; C Botschev; D Naber; D Welter
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effect of antidepressant and neuroleptic drugs on the electrically evoked release of serotonin from rat cerebral cortex.

Authors:  G Gross; K Hante; M Göthert
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Effect of long term treatment with atypical neuroleptic drugs on beta adrenoceptor binding in rat cerebral cortex and myocardium.

Authors:  G Gross; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

6.  Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.

Authors:  R Jackisch; S Moll; T J Feuerstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

7.  Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations.

Authors:  C Rüdeberg; S Urwyler; C Schulthess; P L Herrling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.